80 related articles for article (PubMed ID: 36681612)
1. Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma.
van Akkooi ACJ; Schadendorf D; Eggermont AMM
Eur J Cancer; 2023 Mar; 182():163-169. PubMed ID: 36681612
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy.
Kött J; Zimmermann N; Zell T; Rünger A; Heidrich I; Geidel G; Smit DJ; Hansen I; Abeck F; Schadendorf D; Eggermont A; Puig S; Hauschild A; Gebhardt C
Eur J Cancer; 2024 May; 202():113989. PubMed ID: 38518535
[TBL] [Abstract][Full Text] [Related]
3. Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.
Masoud SJ; Perone JA; Farrow NE; Mosca PJ; Tyler DS; Beasley GM
Curr Treat Options Oncol; 2018 Sep; 19(11):55. PubMed ID: 30232648
[TBL] [Abstract][Full Text] [Related]
4. Investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey.
Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
J Plast Reconstr Aesthet Surg; 2024 Apr; 91():167-172. PubMed ID: 38417393
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients.
Dixon AJ; Kyrgidis A; Steinman HK; Dixon JB; Sladden M; Garbe C; Lallas A; Zachary CB; Leiter-Stöppke U; Smith H; Nirenberg A; Zouboulis CC; Longo C; Argenziano G; Apalla Z; Popescu C; Tzellos T; Anderson S; Nanz L; Cleaver L; Thomas JM
J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):741-751. PubMed ID: 38168748
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: A population-based analysis.
Sharon CE; Straker RJ; Gimotty PA; Chu EY; Mitchell TC; Miura JT; Marchetti MA; Bartlett EK; Karakousis GC
J Am Acad Dermatol; 2023 Apr; 88(4):802-807. PubMed ID: 36442639
[TBL] [Abstract][Full Text] [Related]
7. Primary Melanoma Histopathologic Predictors of Sentinel Lymph Node Positivity: A Proposed Scoring System for Risk Assessment and Patient Selection in a Clinical Setting.
Jeremić J; Radenović K; Jurišić M; Suđecki B; Marinković M; Mihaljević J; Radosavljević I; Jovanović M; Stojanović M; Milić N; Pavlović V; Stojičić M; Inić Z; Jović M
Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003969
[No Abstract] [Full Text] [Related]
8. Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesia.
Huynh J; Leiter U; Garbe C; Shiderova G; Walter V; Eigentler T; Scheu A; Häfner HM; Schnabl SM
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):84-92. PubMed ID: 37611257
[TBL] [Abstract][Full Text] [Related]
9. Completely resected stage III melanoma controversy - 15 years of national tertiary centre experience.
Peric B; Milicevic S; Perhavec A; Hocevar M; Zgajnar J
Radiol Oncol; 2020 Oct; 55(1):50-56. PubMed ID: 33885234
[TBL] [Abstract][Full Text] [Related]
10. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
Broman KK; Hughes TM; Bredbeck BC; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; O'shea K; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Hotz M; Farma JM; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley GM; Hui JYC; Been L; Kruijff S; Sinco B; Sarnaik AA; Sondak VK; Zager JS; Dossett LA;
Ann Surg; 2023 May; 277(5):e1106-e1115. PubMed ID: 35129464
[TBL] [Abstract][Full Text] [Related]
11. Survival benefit of sentinel lymph node biopsy in Asian melanoma patients.
Hsu CC; Liao YH; Sheen YS
Pigment Cell Melanoma Res; 2023 Nov; 36(6):522-530. PubMed ID: 37468225
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy: A multicenter prospective Dutch study.
Stassen RC; Mulder EEAP; Mooyaart AL; Francken AB; van der Hage J; Aarts MJB; van der Veldt AAM; Verhoef C; Grünhagen DJ
Eur J Surg Oncol; 2023 Dec; 49(12):107249. PubMed ID: 37907016
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of sentinel lymph node biopsy for skin cancer in Japan: Comparison with breast cancer and evaluation of factors related to its use.
Wada S; Watanabe T; Ishii T; Ichinose Y; Rikitake R; Ogata D; Nakano E; Namikawa K; Yamazaki N; Higashi T
Cancer Med; 2023 Dec; 12(23):21364-21372. PubMed ID: 37902245
[TBL] [Abstract][Full Text] [Related]
14. Is sentinel lymph node biopsy needed for lentigo maligna melanoma?
Kakish H; Lal T; Thuener JE; Bordeaux JS; Mangla A; Rothermel LD; Hoehn RS
J Surg Oncol; 2024 Mar; 129(4):804-812. PubMed ID: 38018361
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of sentinel lymph node status in thin melanoma: a retrospective analysis.
Meves ES; Meves A
Int J Dermatol; 2024 Apr; 63(4):526-527. PubMed ID: 38149498
[No Abstract] [Full Text] [Related]
16. The Role of Sentinel Node Biopsy in the Era of Adjuvant Therapy for Melanoma.
Brancaccio G; Briatico G; Scharf C; Colella G; Docimo G; Docimo L; Faenza M; Iovino F; Tolone S; Verolino P; Napolitano S; Troiani T; Ronchi A; Franco R; Argenziano G
Dermatol Pract Concept; 2024 Jan; 14(1):. PubMed ID: 38236993
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
Grossman D; Okwundu N; Bartlett EK; Marchetti MA; Othus M; Coit DG; Hartman RI; Leachman SA; Berry EG; Korde L; Lee SJ; Bar-Eli M; Berwick M; Bowles T; Buchbinder EI; Burton EM; Chu EY; Curiel-Lewandrowski C; Curtis JA; Daud A; Deacon DC; Ferris LK; Gershenwald JE; Grossmann KF; Hu-Lieskovan S; Hyngstrom J; Jeter JM; Judson-Torres RL; Kendra KL; Kim CC; Kirkwood JM; Lawson DH; Leming PD; Long GV; Marghoob AA; Mehnert JM; Ming ME; Nelson KC; Polsky D; Scolyer RA; Smith EA; Sondak VK; Stark MS; Stein JA; Thompson JA; Thompson JF; Venna SS; Wei ML; Swetter SM
JAMA Dermatol; 2020 Sep; 156(9):1004-1011. PubMed ID: 32725204
[TBL] [Abstract][Full Text] [Related]
18. Omission of Completion Lymph Node Dissection in Sentinel Node Biopsy Positive Head and Neck Cutaneous Melanoma Patients.
Kesmodel SB; Kronenfeld JP; Zhao W; Koru-Sengul T; Goel N; Weingrad DN; Hernandez-Aya L; Lutzky J; Feun L; Garland-Kledzik M; Crystal JS
Ann Surg Oncol; 2023 Nov; 30(12):7671-7685. PubMed ID: 37639029
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
Maddineni S; Dizon MP; Muralidharan V; Young LA; Sunwoo JB; Baik FM; Swetter SM
Ann Surg Oncol; 2024 Apr; 31(4):2737-2746. PubMed ID: 38216800
[TBL] [Abstract][Full Text] [Related]
20. Oncologic Outcome of Robotic-Assisted and Laparoscopic Sentinel Node Biopsy in Endometrial Cancer.
Ignatov A; Mészáros J; Ivros S; Gennari P; Ignatov T
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
